blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0949928

EP0949928 - ANDROGENIC AND BISPHOSPHONIC AGENTS COADMINISTERED TO TREAT DISEASES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  10.10.2003
Database last updated on 28.09.2024
Most recent event   Tooltip05.06.2009Change - representativepublished on 08.07.2009  [2009/28]
Applicant(s)For all designated states
Merck & Co., Inc.
126 East Lincoln Avenue
Rahway, New Jersey 07065 / US
[N/P]
Former [1999/42]For all designated states
MERCK & CO., INC.
126 East Lincoln Avenue
Rahway, New Jersey 07065 / US
Inventor(s)01 / SCHMIDT, Azriel
126 East Lincoln Avenue
Rahway, NJ 07065 / US
02 / RODAN, Gideon
126 East Lincoln Avenue
Rahway, NJ 07065 / US
03 / HARADA, Shun-Ichi
126 East Lincoln Avenue
Rahway, NJ 07065 / US
[1999/42]
Representative(s)Horgan, James Michael Frederic, et al
Merck & Co., Inc.
European Patent Department
Terlings Park
Eastwick Road, Harlow
Essex CM20 2QR / GB
[N/P]
Former [2009/28]Horgan, James Michael Frederic, et al
Merck & Co., Inc. European Patent Department Terlings Park Eastwick Road Harlow
Essex CM20 2QR / GB
Former [1999/42]Horgan, James Michael Frederic, et al
Merck & Co., Inc., Terlings Park, Eastwick Road
Harlow, Essex CM20 2QR / GB
Application number, filing date97949529.821.11.1997
[1999/42]
WO1997US21306
Priority number, dateUS19960031734P25.11.1996         Original published format: US 31734 P
US19960032341P04.12.1996         Original published format: US 32341 P
GB1997000069715.01.1997         Original published format: GB 9700697
[1999/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO9823274
Date:04.06.1998
Language:EN
[1998/22]
Type: A1 Application with search report 
No.:EP0949928
Date:20.10.1999
Language:EN
The application published by WIPO in one of the EPO official languages on 04.06.1998 takes the place of the publication of the European patent application.
[1999/42]
Search report(s)International search report - published on:US04.06.1998
(Supplementary) European search report - dispatched on:EP27.07.2000
ClassificationIPC:A61K31/56, A61K31/66, // (A61K31/66, 31:56)
[2000/37]
CPC:
A61K31/66 (EP); A61P19/08 (EP); A61P19/10 (EP);
A61P3/14 (EP)
C-Set:
A61K31/66, A61K2300/00 (EP);
A61K31/66, A61K31/565 (EP)
Former IPC [1999/42]A61K31/56, A61K31/66
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1999/42]
TitleGerman:ZUSAMMEN VERABREICHTE ANDROGENE UND DIPHOSPHONVERBINDUNGEN ZUR BEHANDLUNG VON KRANKHEITEN[1999/42]
English:ANDROGENIC AND BISPHOSPHONIC AGENTS COADMINISTERED TO TREAT DISEASES[1999/42]
French:AGENTS ANDROGENE ET BISPHOSPHONIQUE COADMINISTRES POUR TRAITER DES MALADIES[1999/42]
Entry into regional phase25.06.1999National basic fee paid 
25.06.1999Search fee paid 
25.06.1999Designation fee(s) paid 
25.06.1999Examination fee paid 
Examination procedure25.06.1998Request for preliminary examination filed
International Preliminary Examining Authority: US
25.06.1999Examination requested  [1999/42]
07.03.2002Despatch of a communication from the examining division (Time limit: M06)
27.08.2002Reply to a communication from the examining division
12.11.2002Despatch of a communication from the examining division (Time limit: M06)
13.05.2003Application deemed to be withdrawn, date of legal effect  [2003/48]
26.06.2003Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2003/48]
Fees paidRenewal fee
30.11.1999Renewal fee patent year 03
30.11.2000Renewal fee patent year 04
30.11.2001Renewal fee patent year 05
07.11.2002Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]EP0555845  (MITSUBISHI CHEM IND [JP]) [X] 1,3-9 * page 3, lines 29-32 * * claims 2,3 * * page 2, lines 4-33 * [Y] 1-9;
 [Y]WO9324128  (MATTERN ET PARTNER PHARMAZEUTI [DE], et al) [Y] 1-9 * abstract *;
 [Y]WO9414455  (MERCK & CO INC [US], et al) [Y] 1-9 * abstract *;
 [Y]WO9214474  (NORWICH EATON PHARMA [US]) [Y] 1-9 * abstract *
 [Y]  - WANG, C. (1) ET AL, "Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypogonadal men: A clinical research center study.", JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, (1996) VOL. 81, NO. 10, PP. 3654-3662., XP000916279 [Y] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1210/jc.81.10.3654
 [Y]  - GLUECK, CHARLES J. (1) ET AL, "Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with stanozolol.", AMERICAN JOURNAL OF HEMATOLOGY, (1995) VOL. 48, NO. 4, PP. 213-220., XP000916283 [Y] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1002/ajh.2830480402
 [Y]  - REID, IAN R. (1) ET AL, "Glucocorticoid osteoporosis.", JOURNAL OF ASTHMA, (1994) VOL. 31, NO. 1, PP. 7-18., XP000916273 [Y] 1-9 * page 12, column R, lines 11-17 * * page 12, column R, line 44 - page 13, column L, line 22 *

DOI:   http://dx.doi.org/10.3109/02770909409056764
 [Y]  - CHESTNUT, CHARLES H., III (1) ET AL, "Alendronate treatment of the postmenopausal osteoporotic woman: Effect of multiple dosages on bone mass and bone remodeling.", AMERICAN JOURNAL OF MEDICINE, (1995) VOL. 99, NO. 2, PP. 144-152., XP000916282 [Y] 1-9 * abstract *

DOI:   http://dx.doi.org/10.1016/S0002-9343(99)80134-X
International search[Y]US5284841  (CHU LIN [US], et al);
 [Y]US5547685  (CULLINAN GEORGE J [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.